MediWound MDWD
NASDAQ MDWD
$13.21 +0.10 (+0.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

MediWound (MDWD) Consolidated Net Income (2013 - 2026)

MediWound (MDWD) posted quarterly Consolidated Net Income of -$7.7 million for Q4 2025, down 27.03% year-over-year from -$10.6 million in Q4 2024, and down 19.39% quarter-over-quarter from -$6.5 million in Q3 2025.

MediWound (MDWD) Consolidated Net Income (2013 - 2026) Analysis & Trends

MediWound's Consolidated Net Income history runs 13 years deep, the most recent figure standing at -$7.7 million for Q4 2025.

  • In Q4 2025, Consolidated Net Income fell 27.03% year-over-year to -$7.7 million; the TTM figure through Dec 2025 stood at -$32.7 million (down 54.34% YoY), while the FY2025 annual figure was -$23.7 million, up 21.31% from the prior year.
  • Consolidated Net Income for Q4 2025 stood at -$7.7 million, down from -$6.5 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $940000.0 in Q2 2023, with the low at -$13.2 million in Q2 2025.
  • The 5-year median for Consolidated Net Income is -$4.2 million (2022), against an average of -$4.7 million.
  • The sharpest annual moves came in 2021 and 2023: Consolidated Net Income slumped 138500.0% in 2021, then soared 121.63% in 2023.
  • MediWound's Consolidated Net Income stood at -$4.2 million in 2021, then tumbled by 76.47% to -$7.3 million in 2022, then jumped by 76.78% to -$1.7 million in 2023, then slumped by 257.61% to -$6.1 million in 2024, then decreased by 27.03% to -$7.7 million in 2025.
  • Business Quant data shows MDWD's Consolidated Net Income at -$7.7 million in Q4 2025, -$6.5 million in Q3 2025, and -$13.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -174.37 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 MediWound 170.65 Mn 139.65 Mn 337,000.00 -7.39 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.42 Mn
Dec 31, 2025 -7.73 Mn
Sep 30, 2025 -6.47 Mn
Jun 30, 2025 -13.24 Mn
Mar 31, 2025 -5.22 Mn
Dec 31, 2024 -6.08 Mn
Sep 30, 2024 -5.06 Mn
Jun 30, 2024 -6.31 Mn
Mar 31, 2024 -3.71 Mn
Dec 31, 2023 -1.70 Mn
Sep 30, 2023 -2.10 Mn
Jun 30, 2023 940,000.00
Mar 31, 2023 -3.68 Mn
Dec 31, 2022 -7.33 Mn
Sep 30, 2022 -4.19 Mn
Jun 30, 2022 -4.35 Mn
Mar 31, 2022 -3.58 Mn
Dec 31, 2021 -4.15 Mn
Sep 30, 2021 -3.34 Mn
Mar 31, 2021 -2.85 Mn